Molecular Partners Ag (MOLN) EV to EBITDA (2022)
Molecular Partners Ag's (MOLN) EV to EBITDA came in at -0.26 for Q4 2022.
Powered by 
Analysis
Molecular Partners Ag (MOLN) EV to EBITDA (2022) Analysis & Trends
For FY2022, Molecular Partners Ag's EV to EBITDA stood at -0.27.
- Quarterly EV to EBITDA has run from a low of -0.45 in Q3 2022 to a high of 2.88 in Q1 2022 over five years.
- According to Business Quant data, EV to EBITDA for the three prior quarters was -0.45 (Q3 2022), 0.76 (Q2 2022) and 2.88 (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - |
API Access
Molecular Partners Ag EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();